CDTX vs GPC · rev $1.3M vs P/E 21, rev $23.49B
Cidara Therapeutics Inc (CDTX) versus Genuine Parts Co (GPC) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Genuine Parts Co (GPC) is a auto parts company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported GPC revenue for 2024-12-31 was $23.49B. Net income was $904.1M. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
CDTX currently screens at market cap $6.96B. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
Not investment advice. Open the CDTX and GPC stock pages for the full models.
Not investment advice.